Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

CVRX


Fundamental

Company: CVRx Inc
Sector: Healthcare
Industry: Medical Devices
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -2.02
Insider Own: 39.76%
Shs Outstand: 26.19M
Perf Week: -35.76%
Market Cap: 136.55M
Forward P/E: -
EPS next Y: -1.93
Insider Trans: -0.60%
Shs Float: 15.79M
Perf Month: -37.38%
Enterprise Value: 101.95M
PEG: -
EPS next Q: -0.44
Inst Own: 30.49%
Short Float: 8.50%
Perf Quarter: -45.22%
Income: -52.02M
P/S: 2.44
EPS this Y: 23.52%
Inst Trans: -2.77%
Short Ratio: 5.94
Perf Half Y: -34.87%
Sales: 55.97M
P/B: 2.84
EPS next Y Percentage: 4.67%
ROA: -43.53%
Short Interest: 1.34M
Perf YTD: -26.62%
Book/sh: 1.83
P/C: 1.60
EPS next 5Y: 14.99%
ROE: -91.88%
52W High: 18.55 -71.91%
Perf Year: -69.35%
Cash/sh: 3.25
P/FCF: -
EPS past 3/5Y: -7.91% -28.44%
ROIC: -52.96%
52W Low: 4.30 21.18%
Perf 3Y: -63.84%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: 57.87% 52.31%
Gross Margin: 83.15%
Volatility W: 17.02%
Volatility M: 8.79%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 1.82
EPS Y/Y TTM: 25.42%
Oper. Margin: -89.97%
ATR (14): 0.67
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 8.60
Sales Y/Y TTM: 18.44%
Profit Margin: -92.95%
RSI (14): 23.12
Recom: 1.57
Dividend Gr. 3/5Y: - -
Current Ratio: 9.62
EPS Q/Q: 14.45%
SMA20: -28.43%
Beta: 1.27
Target Price: 11.50
Payout: -
Debt/Eq: 1.05
Sales Q/Q: 9.85%
SMA50: -38.18%
Rel Volume: 1.80
Prev Close: 5.47
Employees: 206
LT Debt/Eq: 1.04
Earnings: Nov 05 AMC
SMA200: -33.13%
Avg Volume: 225.77K
Price: 5.21
IPO: Jun 30, 2021
Option/Short: Yes / Yes
EPS/Sales Surpr.: 0.59% 1.99%
Trades:
Volume: 406,560
Change: -4.75%

Technical:


Latest News:

Analysts' Top Healthcare Picks: Adverum Biotechnologies (ADVM), Gilead Sciences (GILD) somewhat bullish
ADVM GILD CVRX

Summary: Analysts are bullish on Adverum Biotechnologies (ADVM), Gilead Sciences (GILD), and CVRx (CVRX) in the Healthcare sector.

Full article
2025-02-13T15:11:42Z
William Blair cuts CVRx stock rating on salesforce issues - Investing.com somewhat bearish
CVRX

Summary: CVRx Inc (NASDAQ:CVRX) was downgraded by William Blair from Outperform to Market Perform due to first-quarter sales falling short of expectations, leading to lower revenue guidance and internal salesforce issues impacting performance.

Full article
2024-05-01T17:35:02Z